407
Views
15
CrossRef citations to date
0
Altmetric
Review Article

Magnetic resonance spectroscopy: principles and applications in neurosurgery

&
Pages 5-13 | Received 02 Jul 2008, Accepted 19 Sep 2008, Published online: 06 Jul 2009

References

  • Provencher S W. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993; 30: 672–679
  • Allen P S, Thompson R B, Wilman A H. Metabolite-specific NMR spectroscopy in vivo. NMR Biomed 1998; 10: 435–444
  • Srinivasan R, Vigneron D, Sailasuta N, Hurd R, Nelson S. A comparative study of myo-inositol quantification using LCModel at 1.5 T and 3.0 T with 3D1H proton spectroscopic imaging of the human brain. Magn Reson Imaging 2004; 22: 523–528
  • Frahm J, Bruhn H, Gynbgell M L, Merboldt K D, Hanick W, Sauter R. Localized high-resolution proton NMR spectroscopy using stimulated echoes: initial applications to human brain in vivo. Magn Reson Med 1989; 9: 79–93
  • Bottomley P A. Spatial localization in NMR spectroscopy in vivo. Ann NY Acad Sci 1987; 508: 333–348
  • Doddrell D M, Galloway G, Brooks W, Field J, Bulsing J, Irving M, Baddely H. Water signal elimination in vivo using suppression by mistimed echo and repetitive gradient episodes. J Magn Reson 1986; 70: 176–180
  • Brown T R, Kincaid B M, Ugurbil K. NMR chemical shift imaging in three dimensions. Proc Natl Acad Sci USA 1982; 79: 3523–3526
  • Nicoli F, Vion-Dury J, Confort-Gouny S, Maillet S, Gastaut J-L, Cozzome P J. Cerebrospinal fluid metabolic profiles in multiple sclerosis and degenerative dementias obtained by high resolution proton magnetic resonance spectroscopy. CR Acad Sci Paris 1996; 319: 623–631
  • McLean M A, Woermann F G, Barker G J, Duncan J S. Quantitative analysis of short echo time 1H-MRSI of cerebral grey and white matter. Magn Reson Med 2000; 44: 401–411
  • Noworolski S M, Nelson S J, Henry R G, Day M R, Wald L L, Star-Lack J, Vigneron D B. High spatial resolution 1H-MRSI and segmented MRI of cortical gray matter and subcortical white matter in three regions of the human brain. Magn Reson Med 1999; 41: 21–29
  • Clayton D B, Elliot M A, Leigh J S, Lenkinski R E. 1H spectroscopy without solvent suppression: characterization of signal modulations at short echo times. J Magn Reson 2001; 153: 203–209
  • Howe F A, Barton S J, Cudlip S A, Stubbs M, Saunders D E, Murphy M, Wilkins P, Opstad K S, Doyle V L, McLean M A, Bell B A, Griffiths J R. Metabolic profiles of human brain tumours using quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med 2003; 49: 223–232
  • Hetherington H P, Pan J W, Mason G F, Ponder S L, Twieg D B, Deutsch G, Mountz J, Pohost G M. 2D 1H spectroscopic imaging of the human brain at 4.1 T. Magn Reson Med 1994; 32: 530–534
  • Behar K L, Rothman D L, Spencer D D, Petroff O AC. Analysis of macromolecule resonances in 1H NMR spectra of human brain. Magn Reson Med 1994; 32: 294–302
  • Davie C A, Hawkins C P, Barker G J, et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 1994; 117: 49–58
  • Hugg J W, Kuzniecky R I, Gilliam F G, et al. Normalization of contralateral metabolic function following temporal lobectomy demonstrated by 1H magnetic resonance spectroscopic imaging. Ann Neurol 1996; 40: 236–239
  • Leary S M, Brex P A, MacManus D G, Parker G J, Barker G J, Miller D H, Thompson A J. A (1)H magnetic resonance spectroscopy study of ageing in parietal white matter: implications for trials in multiple sclerosis. Magn Reson Imaging 2000; 18: 455–459
  • Brand A, Richter-Landsberg C, Liebfritz D. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 1993; 15: 289–298
  • Bruhn H, Frahm J, Merboldt K D, Hanicke W, Hanefeld F, Christen H J, Kruse B, Bauer H J. Multiple sclerosis in children: cerebral metabolic alterations monitored by localized proton magnetic resonance spectroscopy in vivo. Ann Neurol 1992; 32: 140–150
  • Woermann F G, McLean M A, Bartlett P A, et al. Quantitative short echo time proton magnetic resonance spectroscopic imaging study of malformations of cortical development causing epilepsy. Brain 2001; 124: 427–436
  • Castillo M, Smith J K, Kwock L. Correlation of myo-inositol levels and grading of cerebral astrocytomas. AJNR Am J Neuroradiol 2000; 21: 1645–1649
  • Pan J W, Mason G F, Pohost G M, Hetherington H P. Spectroscopic imaging of human brain glutamate by water-suppressed J-refocused coherence transfer at 4.1T. Magn Reson Med 1996; 36: 7–12
  • Petroff O AC, Mattson R H, Rothman D L. Proton MRS: GABA and glutamate. Functional Imaging in the Epilepsies, T R Henry, J S Duncan, S F Berkovic. Philadelphia, Lippincott Williams, Wilkins 2000; 261–271
  • Pirzkall A, Nelson S J, McKnight T R, Takahashi M M, Li X, Graves E E, Verhey L J, Wara W W, Larson D A, Sneed P K. Metabolic imaging of low-grade gliomas with three-dimensional magnetic resonance spectroscopy. Int J Radiat Oncol Biol Phys 2002; 53: 1254–1264
  • Aboagye E O, Bujwalla Z M, Shungu D C, Glickson J D. Detection of tumor response to chemotherapy by 1H nuclear magnetic resonance spectroscopy: effect of 5-fluorouracil on lactate levels in radiation-induced fibrosarcoma 1 tumors. Cancer Res 1998; 58: 1063–1067
  • Tarnawski R, Sokol M, Pieniazek P, Maciejewski B, Walecki J, Miszcyzyk L, Krupska T. 1H-MRS in vivo predicts the early treatment oucome of postoperative radiotherapy for malignant gliomas. Int J Radiat Oncol Biol Phys 2002; 52: 1271–1276
  • Li X, Kin H, Lu Y, Oh J, Chang S, Nelson S J. Identification of MRI and 1H MRSI parameters that may predict survival for patients with malignant gliomas. NMR Biomed 2004; 17: 10–20
  • Hofmann L, Slotboom J, Boesch C, Kreis R. Characterization of the macromolecule baseline in localized 1H-MR spectra of human brain. Magn Reson Med 2001; 46: 855–863
  • McLean M A, Barker G J. Concentrations and magnetization transfer ratios of metabolites in gray and white matter. Magn Reson Med 2006; 56: 1365–1370
  • Lai P H, Hsu S S, Ding S W, Ko C W, Fu J H, Weng M J, Yeh L R, Wu M T, Liang H L, Chen C K, Pan H B. Proton magnetic resonance spectroscopy and diffusion-weighted imaging in intracranial cystic mass lesions. Surg Neurol 2007; 68(suppl 1)S25–S36
  • Omuro A M, Leite C C, Mokhtari K, Delattre J Y. Pitfalls in the diagnosis of brain tumours. Lancet Neurol 2006; 5: 937–948
  • Luthra G, Parihar A, Nath K, Jaiswal S, Prasad K N, Husain N, Husain M, Singh S, Behari S, Gupta R K. Comparative evaluation of fungal, tubercular, and pyogenic brain abscesses with conventional and diffusion MR imaging and proton MR spectroscopy. AJNR Am J Neuroradiol 2007; 28: 1332–1338
  • Saindane A M, Cha S, Law M, Xue X, Knopp E A, Zagzag D. Proton MR spectroscopy of tumefactive demyelinating lesions. AJNR Am J Neuroradiol 2002; 23: 1378–1386
  • Vuori K, Kankaanranta L, Hakkinen A M, et al. Low-grade gliomas and focal cortical developmental malformations: differentiation with proton MR spectroscopy. Radiology 2004; 230: 703–708
  • Tate A R, Underwood J, Acosta D M, Julia-Sape M, Majos C, Moreno-Torres A, Howe F A, van der Graaf M, Lefournier V, Murphy M M, Loosemore A, Ladroue C, Wesseling P, Luc Bosson J, Cabanas M E, Simonetti A W, Gajewicz W, Calvar J, Capdevila A, Wilkins P R, Bell B A, Remy C, Heerschap A, Watson D, Griffiths J R, Arus C. Development of a decision support system for diagnosis and grading of brain tumours using in vivo magnetic resonance single voxel spectra. NMR Biomed 2006; 19: 411–434
  • Opstad K S, Bell B A, Griffiths J R, Howe F A. An investigation of human brain tumour lipids by high-resolution magic angle spinning 1H MRS and histological analysis. NMR Biomed 2007; 20: 1–9
  • Jenkinson M D, Smith T S, Joyce K, Fildes D, du Plessis D G, Warnke P C, Walker C. MRS of oligodendroglial tumors: correlation with histopathology and genetic subtypes. Neurology 2005; 64: 2085–2089
  • Hall W A, Truwit C L. Intraoperative MR-guided neurosurgery. J Magn Reson Imaging 2008; 27: 368–375
  • Hollingworth W, Medina L S, Lenkinski R E, Shibata D K, Bernal B, Zurakowski D, Comstock B, Jarvik J G. A systematic literature review of magnetic resonance spectroscopy for the characterization of brain tumours. AJNR 2006; 27: 1404–1411
  • Pirzkall A, Li X, Oh J, Chang S, Berger M S, Larson D A, Verhey L J, Dillon W P, Nelson S J. 3D MRSI for resected high-grade gliomas before RT: tumor extent according to metabolic activity in relation to MRI. Int J Radiat Biol Phys 2004; 59: 126–137
  • Chuang C F, Chan A A, Larson D, Verhey L J, McDermott M, Nelson S J, Pirzkall A. Potential value of MR spectroscopic imaging for the radiosurgical management of patients with recurrent high-grade gliomas. Technol Cancer Res Treat 2007; 6: 375–382
  • Cendes F, Andermann F, Dubeau F, et al. Normalization of neuronal metabolic dysfunction after surgery for temporal lobe epilepsy. Evidence from proton MR spectroscopic imaging. Neurology 1997; 49: 1525–1533
  • Willmann O, Wennberg R, May T W, Pohlmann-Eden B. The role of 1H magnetic resonance spectroscopy in pre-operative evaluation for epilepsy surgery. A meta-analysis. Epilepsy Res 2006; 71: 149–158
  • Knowlton R C, Laxer K D, Ende G, Hawkins R A, Wong S T, Matson G B, Rowley H A, Fein G, Weiner M W. Presurgical multimodality neuroimaging in electroencephalo-graphic lateralized temporal lobe epilepsy. Ann Neurol 1997; 42: 829–837
  • Serles W, Li L M, Antel S B, Cendes F, Gotman J, Olivier A, Andermann F, Dubeau F, Arnold D L. Time course of postoperative recovery of N-acetyl-aspartate in temporal lobe epilepsy. Epilepsia 2001; 42: 190–197
  • Kuzniecky R, Palmer C, Hugg J, et al. Magnetic resonance spectroscopic imaging in temporal lobe epilepsy: neuronal dysfunction or cell loss?. Arch Neurol 2001; 58: 2048–2053
  • Cross J H, Connelly A, Jackson G D, et al. Proton magnetic resonance spectroscopy in children with temporal lobe epilepsy. Ann Neurol 1996; 39: 107–113
  • Kreis R, Ernst T, Ross B D. Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Reson Med 1993; 30: 424–437
  • Mueller S G, Laxer K D, Barakos J A, Cashdollar N, Flenniken D L, Vermathen P, Matson G B, Weiner M W. Identification of the epileptogenic lobe in neocortical epilepsy with proton MR spectroscopic imaging. Epilepsia 2004; 45: 1580–1589
  • Woermann F G, McLean M A, Bartlett P A, Barker G J, Duncan J S. Quantitative short echo time proton MRSI in malformations of cortical development causing epilepsy: widespread cortical and subcortical abnormalities. Brain 2001; 124: 427–436
  • Cohen B A, Inglese M, Rusinek H, Babb J S, Grossman R I, Gonen O. Proton MR spectroscopy and MRI-volumetry in mild traumatic brain injury. AJNR Am J Neuroradiol 2007; 28: 907–913
  • Gillard J H, Waldman A D, Barker P B. Clinical MR Neuroimaging: Diffusion, Perfusion and Spectroscopy. Cambridge University Press, Cambridge 2004

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.